Neonatal Jaundice Management

Universal Screening and Risk Assessment

The American Academy of Pediatrics recommends that all newborns undergo systematic assessment for jaundice risk before discharge from the hospital 2
The American Academy of Pediatrics suggests measuring transcutaneous bilirubin (TcB) or total serum bilirubin (TSB) on every infant who appears jaundiced in the first 24 hours after birth 3
Plotting the bilirubin level on the hour-specific Bhutani nomogram is recommended to determine risk zone (low, intermediate, or high risk) 4, 3
Visual estimation alone is unreliable and should never be used as the sole assessment method, particularly in darkly pigmented infants 1, 3
Documenting risk factors, including gestational age 35-37 weeks, exclusive breastfeeding, previous sibling with jaundice requiring phototherapy, cephalohematoma, East Asian race, and maternal blood group incompatibility, is recommended 5

The American Academy of Pediatrics recommends that the timing of post-discharge follow-up is determined by when the infant was discharged, not by clinical judgment alone 5, 6
Infants discharged before 24 hours must be seen by 72 hours, those discharged between 24-47.9 hours must be seen by 96 hours, and those discharged between 48-72 hours must be seen by 120 hours 5, 6
Infants discharged before 48 hours may require two follow-up visits 5
If adequate follow-up cannot be ensured for high-risk infants, delay discharge until 72-96 hours of age 5, 6

The American Academy of Pediatrics recommends continuing breastfeeding throughout jaundice evaluation and treatment—do not routinely discontinue 7, 2
Advising mothers to nurse 8-12 times per day in the first several days is recommended 2, 8
Poor intake and dehydration from inadequate breastfeeding contribute to hyperbilirubinemia 2, 9
Supplementation with expressed breast milk or formula is appropriate only if intake is inadequate, weight loss is excessive, or the infant appears dehydrated 7

The American Academy of Pediatrics recommends immediately measuring TcB and/or TSB for initial jaundice in the first 24 hours 3
Blood type and Rh of infant and mother, as well as direct Coombs test, should be performed for initial jaundice in the first 24 hours 3
For jaundice requiring phototherapy or rising rapidly, blood type and Coombs, complete blood count with smear, direct or conjugated bilirubin, and reticulocyte count should be performed 3, 9
For jaundice at or beyond 3 weeks, total and direct/conjugated bilirubin should be measured to identify cholestasis 7, 3

The American Academy of Pediatrics recommends using intensive phototherapy when TSB exceeds the hour-specific threshold based on infant's age in hours, gestational age, and presence of neurotoxicity risk factors 7, 3
Intensive phototherapy specifications include irradiance ≥30 μW/cm²/nm in blue-green spectrum (430-490 nm) and delivery to maximum infant surface area 7, 8
Exchange transfusion is required for TSB ≥25 mg/dL (428 μmol/L) at any time, and must be performed only by trained personnel in a neonatal intensive care unit with full monitoring and resuscitation capabilities 6, 7
Immediate exchange transfusion is required for any jaundiced infant showing signs of acute bilirubin encephalopathy, regardless of bilirubin level 7

The American Academy of Pediatrics recommends recognizing signs of acute bilirubin encephalopathy, including lethargy, hypotonia, poor feeding, moderate stupor, irritability, hypertonia, fever, high-pitched cry, and backward arching of neck and trunk 1
Common errors to avoid include relying on visual assessment alone, using TcB measurements in infants receiving phototherapy, and delaying treatment for infants with TSB ≥25 mg/dL by sending to emergency department first 1, 3, 6

The American Academy of Pediatrics recommends measuring TSB every 2-3 hours if TSB ≥25 mg/dL, every 3-4 hours if TSB 20-25 mg/dL, and every 4-6 hours if TSB <20 mg/dL 7
If TSB continues to fall, extend measurement to every 8-12 hours 7
If TSB is not decreasing or continues rising despite intensive phototherapy, hemolysis is very likely occurring—investigate immediately 5

The American Academy of Pediatrics recommends stopping phototherapy when TSB falls to <13-14 mg/dL (239 μmol/L) 7
Consider measuring TSB 24 hours after discharge to check for rebound, depending on the cause of hyperbilirubinemia 7